The Thyroid Disorders Treatment Market was valued at around US$2.1 billion at the end of 2018. The revenue is said to engross over US$2.67 billion by 2026, with a CAGR of 3.52%.
The Gaucher’s Disease Treatment Market was valued at US$1.51 billion in the year 2018 and is estimated to reach US$1.67 billion by 2026, at a CAGR of 1.22%.